Rank;Global Rank;Institution;Country;Sector
1;103;Hypertension Arterielle, Pulmonaire: Physiopathologie et Innovation Therapeutique;FRA;Companies
2;166;GlaxoSmithKline, United Kingdom;GBR;Companies
3;185;Sanofi, France;FRA;Companies
4;228;AstraZeneca, Sweden;SWE;Companies
5;239;AstraZeneca, United Kingdom;GBR;Companies
6;316;Boehringer Ingelheim GmbH Germany;DEU;Companies
7;336;Novartis, Switzerland;CHE;Companies
8;617;Bosch, Germany;DEU;Companies